Evidence map›Paper›PMID 28512124›Full record

ArticleBMJ case reports2017

Use of propranolol in a remote region of rural Guatemala to treat a large facial infantile haemangioma.

Vera Goldberg, Boris Martinez, Katia Cnop, Peter Rohloff

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Vera GoldbergHarvard Medical School, Boston, Massachusetts, USA.
Boris MartinezWuqu' Kawoq, Santiago Sacatepéquez, Guatemala.
Katia CnopWuqu' Kawoq, Santiago Sacatepéquez, Guatemala.
Peter RohloffDivision of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0001-7274-8315
Probigua · GTBrigham and Women's Hospital · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a female infant with a right-sided facial and neck haemangioma, from a remote, resource-poor community in rural Guatemala. She received first-line treatment, propranolol, with marked reduction in tumour size and erythema. Treatment was stopped after 35 weeks due to recurrent diarrhoea and sustained weight loss. Propranolol can be used to safely treat infants with haemangiomas in remote, rural communities if there is adequate follow-up, education and communication. Periocular haemangiomas should be treated promptly to avoid visual impairment. Infants with large facial haemangiomas should be screened for

Indexed as

Aortic CoarctationDiagnosis, DifferentialEye AbnormalitiesFaceFemaleGuatemalaHemangiomaHumansInfantMagnetic Resonance AngiographyMagnetic Resonance ImagingNeurocutaneous SyndromesPropranololRural PopulationTreatment OutcomeVasodilator AgentsPropranololVasodilator AgentsCongenital disordersGlobal HealthHemangiomaPharmacology and therapeutics

Identifiers

PMID28512124
PMCPMC5753702
OpenAlexW2614278175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.